Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 36 holding rows worth $167,046,000.

Accession
0001420506-22-000326
Filed
2022-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 36 entries on the cover page, a total value of $167,046,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $167,046,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PROTHENA CORP PLC SHSG72800108Stock441,000$21,785,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR345,900$19,069,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK514,082$11,973,000thousands by filing date
GALAPAGOS NV36315X901SPON ADR200,300$11,043,000thousands by filing datecall
CUE BIOPHARMA INC22978P106COM829,042$9,376,000thousands by filing date
ENCOMPASS HEALTH CORP COM29261A100Stock122,187$7,974,000thousands by filing date
OSCAR HEALTH INC687793109CL A925,000$7,261,000thousands by filing date
CONVEY HEALTH SOLUTIONS HLDG21258C108CMN777,000$6,496,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM360,000$6,019,000thousands by filing date
ZOGENIX INC.98978L204Common Stock362,909$5,897,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM15,481$5,833,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM409,620$5,419,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock31,907$5,411,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM1,155,300$4,621,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW45,000$4,182,000thousands by filing date
AGILON HEALTH INC00857U107COM150,000$4,050,000thousands by filing date
MORPHIC HLDG INC61775R105COM72,898$3,454,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO356,617$2,857,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM128,705$2,810,000thousands by filing date
PROTHENA CORP PLCG72800908SHS52,100$2,574,000thousands by filing datecall
PROGYNY INC74340E953PUT50,000$2,518,000thousands by filing dateput
SHATTUCK LABS INC82024L103COMMON STOCK260,243$2,215,000thousands by filing date
COGNITION THERAPEUTICS INC19243B102COM301,979$1,909,000thousands by filing date
PANACEA ACQUISITION CORP IIG6882C106COM195,855$1,900,000thousands by filing date
GLOBUS MED INC CL A379577208Stock20,188$1,458,000thousands by filing date
ACCOLADE INC00437E102COM50,000$1,318,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock17,364$1,316,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM68,800$1,313,000thousands by filing date
SIO GENE THERAPIES INC829399104COM802,180$1,035,000thousands by filing date
MODERNA INC60770K107COM3,700$940,000thousands by filing date
WEST PHARMACEUTICAL SVSC INC955306955COM1,500$704,000thousands by filing dateput
CYMABAY THERAPEUTICS INC23257D103COM166,775$564,000thousands by filing date
PROCEPT BIOROBOTICS CORP COM74276L105Stock20,000$500,000thousands by filing date
EXICURE INC30205M101COM2,426,508$490,000thousands by filing date
ODONATE THERAPEUTICS INC676079106COM298,900$404,000thousands by filing date
ARS PHARMACEUTICALS INC82835W108COM53,815$358,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-22-000326this filing2022-02-14acceptance time not in the bulk data set